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Hepatocyte growth factor (HGF) is involved in many cellular responses, such as mitogenesis and apoptosis
protection; however, its effect against oxidative injury induced by ethanol metabolism is not well
understood. The aim of this work was to address the mechanism of HGF-induced protection against ethanol-
generated oxidative stress damage in the human cell line VL-17A (cytochrome P450 2E1/alcohol
dehydrogenase-transfected HepG2 cells). Cells were pretreated with 50 ng/ml HGF for 12 h and then
treated with 100 mM ethanol for 0–48 h. Some parameters of oxidative damage were evaluated. We found
that ethanol induced peroxide formation (3.3-fold) and oxidative damage as judged by lipid peroxidation
(5.4-fold). Damage was prevented by HGF. To address the mechanisms of HGF-induced protection we
investigated the cellular antioxidant system. We found that HGF increased the GSH/GSSG ratio, as well as
SOD1, catalase, and γ-glutamylcysteine synthetase expression. To explore the signaling pathways involved in
this process, VL-17A cells were pretreated with inhibitors against PI3K, Akt, and NF-κB. We found that all
treatments decreased the expression of the antioxidant enzymes, thus abrogating the HGF-induced
protection against oxidative stress. Our results demonstrate that HGF protects cells from the oxidative
damage induced by ethanol metabolism by a mechanism driven by NF-κB and PI3K/Akt signaling.
© 2009 Elsevier Inc. All rights reserved.
Ethanol (EtOH) abuse remains one of the main factors that cause
liver injury. Alcoholic liver disease (ALD) is characterized by several
distinct stages of injury ranging from steatosis to cirrhosis [1,2]. These
deleterious effects are caused by products of EtOHmetabolism such as
acetaldehyde and reactive oxygen species (ROS) generated by EtOH
metabolism [3]. EtOH is detoxified mainly by alcohol dehydrogenase
(ADH) and cytochrome P450 2E1 (Cyp2E1) [3] and both enzymes
generate acetaldehyde, a highly toxic metabolite. Additionally, ethanol
metabolism by Cyp2E1 generates large amounts of ROS, which can be
involved in many harmful processes, such as lipid and protein
oxidation, that can promote cellular dysfunction and eventually cell
death by apoptosis or necrosis [3–6].
Liver cells possess a number of compensatory mechanisms to deal
with ROS and their effects; among these are the induction of
antiapoptotic and antioxidant proteins such as superoxide dismutase
(SOD), catalase, glutathione peroxidase (GSHPx), and the tripeptide
glutathione(GSH), aswell as others [5,7]. Thesemechanismsare induced
in response to the actions of some growth factors and cytokines that
activate survival signaling pathways, such as phosphoinositol 3-kinase
(PI3K), Akt, and nuclear factor-κB (NF-κB) [8–10].
Hepatocyte growth factor (HGF), otherwise known as scatter
factor, is a multifunctional growth factor that supports diverse cellular
process including morphogenesis, motility, proliferation, and apopto-
sis protection [11]. HGF and its receptor c-Met activate signaling
pathways that promote cell survival against apoptotic inducers,
including the Fas agonist Jo2. There are several reports that strongly
support the antiapoptotic effects of HGF/c-Met [8,12–14], mainly by
the induction of antiapoptotic proteins such as Bcl-2, Bcl-XL, or Mcl-1
[14,15]. Although the HGF/c-Met-induced apoptosis protection is well
known, the effect on oxidative stress protection remains not fully
understood. Some published reports indicate that HGF can protect
from oxidative damage [15–17] but the effect of this growth factor on
alcoholic liver damage is practically unexplored. Because ROS are
thought to be important factors that induce cell injury in ALD, we
investigated the capacity of HGF in the protection against ALD, using
the recombinant HepG2 cell line VL-17A, which efficiently expresses
both ADH and CYP2E1 [18]. We also investigated the mechanisms by
which HGF protects cells from the deleterious effects of ROS produced
as a result of ethanol metabolism.
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Materials and methods
Cell culture
HepG2 cells that constitutively and stably express ADH (VA-13) or
both Cyp2E1 and ADH (VL-17A cells) were produced by Dr. Dahn L.
Clemens from the Research Service, The Veterans Affair Medical
Center, and the University of Nebraska Medical Center (Omaha, NE,
USA). HepG2 cells were obtained from the American Type Culture
Collection (Rockville, MD, USA). All cell lines were cultured inminimal
essential medium containing 10% fetal bovine serum and supplemen-
ted with 100 U/ml penicillin and 100 μg/ml streptomycin in a
humidified atmosphere in 5% CO2 at 37°C. Cells were plated and
incubated in minimal essential medium overnight, the culture
mediumwas replaced with fresh medium, and the various treatments
were initiated.
Experimental design
Twenty-four hours after cell plating, the culture media were
replaced with a serum-free medium containing or not containing
100mMEtOH. After incubation for 1, 3, 6,12, 24, or 48 h, the cells were
washed twice with phosphate-buffered saline (PBS), and whole-cell
lysates (WCL) were prepared for Western blot analysis. For HGF
pretreatments cells were treated for 12 h with 50 ng/ml recombinant
human HGF (Peprotech, Rocky Hill, NJ, USA) and then 100 mM EtOH
was added to cell culture for 48 h. At the end of treatment the cells
were subjected to studies or harvested and prepared for Western blot
analysis. To address the participation of some signaling pathways
involved in cell survival, hepatocytes were pretreated for 30 min
before HGF treatment with 10mMwortmannin,10 μMAkt inhibitor II,
and 30 μM SN50, a peptide inhibitor of NF-κB.
Cell lysis and Western blot
WCL were prepared from 1.5×106 cells that were collected and
washed twice with ice-cold PBS. The cell pellet was resuspended in
150 μl of M-PER (Pierce Chemical, Rockford, IL, USA) lysis buffer
supplemented with proteases and phosphatase inhibitors. Lysis was
performed on ice for 15 min, and cell debris was removed by
centrifugation at 13,000g at 4°C for 10 min. The supernatant was
recovered and proteins were separated by electrophoresis using 4–
20% gradient Duramide precast gels (Cambrex, Rockland, ME, USA)
and transferred to a polyvinylidene difluoride membrane (Invitrogen,
Carlsbad, CA, USA). Immunodetection was performed using primary
antibody as indicated, anti-SOD1, anti-GSHPx 1/2, anti-actin, γ-
glutamylcysteine synthetase (γ-GCS) (Santa Cruz Biotechnology,
Santa Cruz, CA, USA), or anti-catalase (Sigma, St. Louis MO, USA),
followed by horseradish peroxidase-conjugated secondary antibody
(Amersham, Piscataway, NJ, USA) and detection by incubation with
SuperSignal West Pico chemiluminescent substrate (Pierce) and
HyperFilm (Amersham).
Reactive oxygen species measurement
Reactive oxygen species levels were determined using 6-carboxy-
2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA) (Sigma). Cells
were treated with 100 mM EtOH for 24 h and then washed with ice-
cold PBS and incubated with 3 μMDCFH-DA for 30 min. The cells were
trypsinized and suspended in ice-cold PBS in the dark, and ROS
generation was measured by flow cytometry using a flow cytometer
(Becton–Dickinson). A minimum of 10,000 cell-gate events was
acquired and analyzed with CellQuest (Becton–Dickinson) software.
Nuclear extract preparation
Cells were washed twice with ice-cold PBS and scraped off from
dishes with a rubber cell lifter. Nuclear extracts were prepared by
lysing cells with Igepal CA-630 (0.58%) in 10 mM Hepes, pH 7.9,
containing 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM
dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl fluoride (PMSF).
Cells were vigorously mixed and centrifuged at 13,000g at 4°C.
Pelleted nuclei were resuspended in 20 mM Hepes, pH 7.9, containing
0.4 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF. After
being mixed continuously for 15 min at 4°C the samples were
centrifuged at 13,000g for 5 min and the supernatants recovered and
stored at −80°C.
Electrophoretic mobility shift assay
Activation of NF-κBwas examined by electrophoretic mobility shift
assay (EMSA) using a consensus oligonucleotide, 5′-AGTTGAGGG-
GACTTTCCCAGGC-3′ (Promega, Madison, WI, USA). Probe was labeled
by T4 polynucleotide kinase (USB, Cleveland, OH, USA) with [γ-32P]
ATP (3000 Ci/mmol; MP Biomedical, Irvine, CA, USA). Labeled probe
was purified using Bio-Spin 30 chromatography columns (Bio-Rad,
Hercules, CA, USA). Binding reactions were done as described by
Roman et al. [19] using 20 μg of protein from nuclear extracts, in 5 μl of
incubation buffer (50mMTris–HCl, pH 7.5, 200mMNaCl, 5 mM EDTA,
5 mM β-mercaptoethanol, and 20% glycerol) and 1 μg poly(dI–dC).
Complexes were separated through nondenaturing 6% polyacrylamide
gels and were visualized by autoradiography. In competition experi-
ments 100-fold molar excess of unlabeled oligonucleotide was added
to the reaction mix for 5 min before addition of the labeled probe.
Cell viability
Cell viability was assessed by the crystal violet-staining assay
according to Nakagawa et al. [20]. Cells seeded at 1×105 into 12-well-
plates were treated and then washed with PBS, fixed with 3.7%
formaldehyde, and stained with 0.2% crystal violet. The absorbance of
the 2% sodium dodecyl sulfate extracts was measured at 620 nm. The
cell viabilitywas calculated as the percentage relative to untreated cells.
5-Bromo-2′-deoxyuridine (BrdUrd) labeling
Proliferationwas analyzed by BrdUrd incorporation using a BrdUrd
labeling kit (Roche Diagnostics GmbH, Mannheim, Germany). Cells
were pretreated or not with 50 ng/ml HGF for 12 h and then treated
with or without 100 mM EtOH for 24, 48, and 72 h and labeled with
10 μM BrdUrd during the last 24 h. Incorporation of BrdUrd was
analyzed by luminescence using a multimode detector 880 (Beckman
Coulter).
GSH determination by HPLC
GSH and oxidized GSH (GSSG) content was determined by HPLC
following a protocol described by Fariss and Reed [21], with some
modifications. Briefly, cells were collected in 1 ml of 10% perchloric
acid and sonicated on ice for 30 s, and the suspension was
centrifuged at 5000g, for 5 min at 4°C. Two hundred fifty milliliters
of the supernatant was removed and transferred to a fresh
microcentrifuge tube for derivatization. Iodoacetic acid (100 mM)
in 0.2 mM m-cresol was added to each sample and to GSH and GSSG
solution standards, the pH was adjusted to 9.0±0.2 with a solution
of 10 M KOH/3 M KHCO3, and the samples were incubated in the
dark at room temperature for 1 h. After that, 1 ml of 1% 1-fluoro-2,4-
dinitrobenzene in 100% HPLC-grade ethanol was added to each
sample and incubated at room temperature and then at 4°C
overnight. The next day, the samples were centrifuged at 13,000g
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at room temperature for 1 min and 100 μl N-DNP derivatives was
injected into the loop of the HPLC system (Waters, Milford, MA,
USA). Separation was achieved on a 3-aminopropyl column (5 μm;
4.6 mm×20 cm; Custom LC, Houston, TX, USA), with initial solvent
conditions of 80% solution A (80% grade HPLC methanol), 20%
solution B (0.5 M sodium acetate in 64% methanol), which were
maintained at 1 ml/min for 10 min. From 10 to 40 min, we a linear
gradient was used, to a final ratio of 1% solution A/99% solution B.
Eluted N-DNP derivatives were measured by ultraviolet detection at
365 nm.
Lipid peroxidation
Lipid peroxidation was assayed by determining the rate of
production of thiobarbituric acid-reactive substances (TBARS) by
spectrophotometry as described by Buege and Aust [22].
Protein oxidation
Oxidative modification of proteins generates protein carbonyl
groups, which represent a hallmark of oxidation status of all proteins.
Carbonyl groups were immunodetected using an Oxyblot kit (Chemi-
con) according to the manufacturer's instructions.
Protein content determination
Protein concentration was determined using a bicinchoninic acid
kit (Pierce Chemical), according to the manufacturer's instructions.
Data analysis
Data are reported as means±SE. The SPSS package version 10 was
used to run the analysis. Comparisons among groups were done by
means of ANOVA. Tukey's method was used for multiple comparisons.
A p≤0.05 was considered statistically significant.
Results
Ethanol metabolism induces oxidative damage
Hepatocytes metabolize EtOH mainly by the action of Cyp2E1 and
ADH. In vitro studies regarding this issue present a challenge because
hepatocytes in primary culture rapidly lose the activity of both
enzymes. To circumvent this problem we used the VL-17A cell line,
which express both Cyp2E1 (Fig. 1A) and ADH, and the VA-13 [23] cell
line, which expresses only ADH. It is well known that Cyp2E1 activity
generates oxidative stress. Figs. 1B and C show that 100 mM EtOH
induced ROS production (Fig. 1B) and lipid peroxidation (Fig. 1C) only
in VL-17A cells in comparison with VA-13 and HepG2 cells. As further
evidence of oxidative damage we assayed protein oxidation in WCL.
Fig. 1D shows that EtOH treatment in VL-17A cells induced significant
protein oxidation. These data are in agreement with many reports
that Cyp2E1 is responsible for EtOH-induced oxidative damage [3,4].
No differences were observed in lipid peroxidation and ROS
production in VA-13 and HepG2 cells (Figs. 1B and C), which confirms
that ADH-mediated EtOH metabolism does not produce detectable
levels of ROS.
Cell injury induced by EtOH was prevented by HGF pretreatment
To address the effects of HGF on EtOH-induced oxidative damage,
VL-17A and HepG2 cells were pretreated or not with 50 ng/ml HGF for
12 h and then exposed for 48 h to 100 mM EtOH. HGF-induced
protection was explored by examining culture morphology by
microscopy. EtOH treatment damaged VL-17A cell culture (Fig. 2F)
in comparison with untreated VL-17A (Fig. 2E) and EtOH-treated
HepG2 cells (Fig. 2B), which do not metabolize EtOH. HGF pretreat-
ment abrogated the deleterious effects of EtOH metabolism, prevent-
ing cell damage (Fig. 2F). To confirm these observations we decided to
determine protein oxidation and lipid peroxidation; results show that
EtOH increased the content of carbonyl groups in WCL (Fig. 2I) and
lipid peroxidation products (TBARS) 4.8-fold compared to untreated
cells (Fig. 2J), which indicates an oxidative damage process. HGF
pretreatment prevented the EtOH metabolism-induced oxidative
damage to control values. These data are in agreement with the cell
viability experiment determined by crystal violet-staining assay. EtOH
decreased cell viability 35% compared with untreated cells and HGF
pretreatment protected cells against EtOH toxicity (Fig. 2K).
Fig. 1. Ethanol metabolism induces oxidative stress. VL-17A, VA-13, and HepG2 cells
were treated or not with 100 mM EtOH for 48 h. (A) Whole-cell lysates prepared from
serum-staved (16 h), untreated cells were immunoblotted with anti-cytochrome P450
2E1 to determine the expression of the enzyme. (B) ROS determination. After EtOH
treatment cells were incubated with the oxidative-sensitive probe DCFH-DA (3 μM) for
30 min and fluorescence was recorded by flow cytometry as indicated under Materials
and methods. Antimycin A (AA) was used as a positive control. (C) Lipid peroxidation
determined by the content of thiobarbituric acid-reactive substances (TBARS) as
indicated under Materials and methods. (D) Protein oxidation determined by protein
carbonyl group content. Each column represents the mean±SEM of at least three
independent experiments. ⁎pb0.05 against HepG2 treated with EtOH. &pb0.05 against
untreated VL-17A cells.
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HGF induces cell survival by a mechanism mediated by NF-κB
To study whether HGF-induced protection is a process mediated
by the well-known survival factor NF-κB, we explored the activation
of this transcription factor. HGF treatment in VL-17A cells exerted a
time-dependent increase in DNA binding of NF-κB as early as 30 min,
which peaked at 120 min (Fig. 3A). To confirm this effect, we
analyzed the degradation of the natural inhibitor of NF-κB (IκB-α) by
Western blot. IκB-α content decreased in a time-dependent manner
and was correlated with NF-κB activation (data not shown). To clarify
that ethanol by itself does not induce NF-κB activation, we performed
an EMSA with nuclear protein from hepatocytes treated with
100 mM EtOH from 30 to 360 min (Fig. 3B), and no changes in the
activation of NF-κB were observed. Furthermore we analyzed
whether pretreatment with HGF for 2 h followed by treatment
with EtOH for an additional 2 h could induce the activation of the
transcription factor. Fig. 3C demonstrates that HGF + EtOH did not
induce any change. To support the participation of NF-κB in HGF-
induced cell protection, we determined cell viability by crystal violet-
staining assay in cells pretreated for 30 min with SN50, a peptide
inhibitor of NF-κB, and after that, we proceeded with the HGF and
EtOH treatments, for 12 and 48 h, respectively. As Fig. 3D shows,
SN50 inhibitor abrogated the protective effect of HGF, decreasing
viability by 61% compared to HGF + EtOH treatment. This result
confirms the participation of NF-κB in the HGF-induced cell
protection against oxidative stress generated by EtOH metabolism.
The effect of SN50 on toxicity of EtOH alone was a slight decrease in
viability in comparison with EtOH (data not shown) confirming that
abrogation of basal NF-κB activity sensitizes cells to die.
HGF-induced NF-κB activation is mediated by the PI3K/Akt pathway
To address the signaling events underlying HGF-induced NF-κB
activation, we decided to explore the inhibition of the main upstream
steps that lead NF-κB activation. PI3K/Akt is the main signaling
pathway that is activated by HGF and other growth factors [8,10,24].
VL-17A cells were pretreated for 30 min with wortmannin, Akt
inhibitor, and SN50 inhibitor as a positive control and then treated
with 50 ng/ml HGF for 120 min, and then EMSA was performed. As
Fig. 4 shows, both wortmannin and Akt inhibitor abrogated HGF-
induced NF-κB activation, suggesting that PI3K and Akt are involved in
NF-κB activation.
HGF enhances the antioxidant system to deal with EtOH toxicity
Because GSH is the main hepatoprotector molecule in the liver, we
decided to explore the GSH/GSSG ratio and the expression of γ-GCS,
the key-step enzyme in GSH synthesis. Fig. 5A shows that HGF
increased the GSH/GSSG ratio by 3-fold in comparisonwith untreated
cells. These data are in agreement with γ-GCS content determined by
Fig. 2. HGF protects against ethanol metabolism-induced oxidative damage. HepG2 or VL-17A cells were pretreated or not with 50 ng/ml HGF for 12 h and then treated or not with
100 mM EtOH for 48 h. (A–H) Images show cell morphology under all experimental conditions in HepG2 and VL-17A cells. Original magnification 200×. (I) Protein oxidation
determined by protein carbonyl group content. (J) Lipid peroxidation determined by the content of TBARS as indicated under Materials and methods. (K) Viability of VL-17A cells as
determined by crystal violet assay. Each column represents themean±SEM of at least three independent experiments. ⁎pb0.05 against not-treated (NT) cells. &pb0.05 against EtOH-
treated VL-17A cells.
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Western blot (Fig. 5B), by which HGF treatment induced the enzyme
2.8-fold compared to untreated cells. EtOH treatment decreased the
GSH/GSSG ratio, but the pretreatment with HGF in the presence of
EtOH restored the ratio to control levels (Fig. 5C).
In addition to the GSH system we investigated the expression of
the antioxidant proteins SOD1, catalase, and GSHPx 1/2 by Western
blot. HGF induced the expression of SOD1 and catalase (Fig. 6A), but
failed to induce GSHPx 1/2 (data not shown). The expression of SOD1
and catalase was time-dependent and peaked at 12 h of HGF exposure
(2.2- and 2.5-fold, respectively) and was associated with the
cytoprotective effect observed in Figs. 2H, I, J, and K. To address the
participation of PI3K/Akt/NF-κB signaling in the regulation of
antioxidant enzymes we pretreated cells with 10 mM wortmannin,
10 μMAkt inhibitor II, and 30 μM SN50. The three inhibitors abrogated
the HGF-induced catalase, SOD1, and γ-GCS (Fig. 6B). These data
suggest that HGF transduces its antioxidant response via the PI3K/
Akt/NF-κB signaling pathway.
HGF improves the EtOH-mediated impairment of cell proliferation
Finally, to correlate the molecular findings with a physiological
process we analyzed cell proliferation, because it is well known that
EtOH impairs cell proliferation [25]. As Fig. 7 shows, EtOH decreased
proliferation at 48 h of treatment compared to untreated cells,
whereas HGF pretreatment moderated this effect significantly.
Discussion
Alcohol-induced damage is a multifactorial process that involves
genetic and environmental factors. Some of these factors are ROS
derived from Cyp2E1-mediated EtOH metabolism in addition to those
generated by mitochondrial dysfunction [26]. Cyp2E1 activity is
increased by 10- to 20-fold in the livers of alcohol-treated rodents
[27]. In humans an increase has been observed, not only in alcohol
abusers, but also inmoderate alcohol consumers [28]. This overactivity
of Cyp2E1 in ALD is tightly linked to ROS production and cell damage
[3,4,29,30], aswe confirmed in thiswork. The recombinantHepG2 cells
VL-17A, which express Cyp2E1 and alcohol dehydrogenase, presented
oxidative damagewhen theywere treated with 100mM EtOH for 48 h
(Figs. 1 and 2F), in comparison with untreated VL-17A cells or HepG2
cells that lack Cyp2E1 activity. Venugopal et al. [30] reported that VL-
17A cells treated with 100 mM EtOH generate ROS that activate PKCδ
and proteasome-mediated degradation of mitogen-activated protein
kinase (MAPK) phosphatase-1, a proteinphosphatase involved in c-Jun
N-terminal kinase dephosphorylation, leading a sustained activation
of this kinase and apoptosis progression.
To deal with oxidative stress, hepatocytes have available a wide
range of antioxidants and survival factors that are induced by changes
in the redox status as an adaptation response and by growth factors as
Fig. 4. HGF-induced NF-κB activation is mediated by PI3K and Akt. Electromobility shift
assay of NF-κB DNA binding activity in serum-starved (16 h) cells. VL-17A cells were
pretreated with 100 nM wortmannin, 10 μM Akt inhibitor II, or 30 μM SN50 for 30 min
and then treated with HGF (50 ng/ml) for 2 h. Image is representative of at least three
independent experiments. ⁎pb0.05 against untreated cells.
Fig. 3. HGF induces NF-κB activation-dependent cell survival. (A) Electromobility shift assay of NF-κB DNA-binding activity in serum-starved (16 h) VL-17A cells treated with (A)
HGF (50 ng/ml) for 15, 30, 60, and 120 min; (B) ethanol (100 mM) for 30, 60, 120, 240, and 360 min; and (C) HGF (50 ng/ml) for 120 min and/or ethanol (100 mM) for 120 min.
(D) Viability of VL-17A cells as determined by crystal violet assay. Each column represents the mean±SEM of at least three independent experiments. ⁎pb0.05 against not-treated
(NT) cells. &pb0.05 against HGF + EtOH-treated cells. #pb0.05 against EtOH-treated VL-17A cells.
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survival responses. Recently it has been proposed that HGF and its
receptor c-Met can regulate the expression of many genes involved in
oxidative stress regulation [31] and even in the regulation of oxidative
stress-related carcinogenesis [17]; however, the mechanism is not
fully characterized. We observed that pretreatment with HGF protects
hepatocytes against oxidative damage induced by EtOH (Fig. 2), which
is in agreement with the effect observed in other cell types [7,15,16].
It is well known that HGF can activate NF-κB, a key downstream
regulatory factor of cell survival [32,33], so we decided to explore the
activation of this transcription factor in VL-17A cells treated with HGF.
Our data revealed that HGF induced NF-κB activation as rapidly as
30min after treatment; this result is in agreementwith those reported
by Fan et al. [32]. These results suggest that HGF exerts a rapid
response of cell survival, mediated by NF-κB, preparing the cells to
deal with insults such as apoptosis inducers [12], hypoxia/reoxygena-
tion-induced oxidative stress [24], or alcohol metabolism-mediated
damage as we presented in this work.
Our data suggest that this response was mediated by PI3K and Akt
activation. It is well documented that this pathway modulates many
functions related to cell survival, proliferation, and liver regeneration
[34] by activating downstream mediators and transcription factor
such as MAPK, the signal transducers and activator of transcription
proteins, and NF-κB [35]. All of these downstream kinases are able to
regulate antiapoptotic response, proliferation, and regeneration, but
in terms of antioxidant defense are not fully characterized.
GSH is the main antioxidant protector against oxidative stress in
the liver and its relevance in ALD [26] and other pathologies has been
well documented. GSH is synthesized in the cytosol as a response to
many signals, including oxidative stress and growth factors [6]. Tsuboi
[36] reported that HGF treatment increased GSH synthesis in rat
hepatocytes via induction of γ-GCS. Our data are in agreement with
these observations; HGF treatment increased the GSH/GSSG ratio in
VL-17A cells as well as γ-GCS expression and these effects were
correlated with cell survival (Fig. 2K). Furthermore, recently Takami et
al. [17] found that c-Met knockout mice present a disruption in redox
homeostasis, which conditioned them to N-nitrosodiethylamine-
induced hepatocarcinogenesis. This effect was abrogated with oral
administration of N-acetyl-L-cysteine (NAC), a well-known GSH
precursor and antioxidant. The same result was observed in c-Met
knockout hepatocytes that present an enhanced sensitization to Fas-
induced apoptosis, which was abrogated by NAC treatment [37]. On
the other hand, it has been reported that HGF can induce gene
Fig. 7. HGF improves the EtOH-mediated impairment of cell proliferation. Proliferation
was analyzed by BrdUrd incorporation using a BrdUrd labeling kit. VL-17A cells were
pretreated or not with 50 ng/ml HGF for 12 h and then treated with or without 100mM
EtOH for 24, 48, and 72 h and labeled with 10 μM BrdUrd during the last 24 h.
Incorporation of BrdUrd was analyzed by luminescence. Each column represents the
mean±SEM of six independent experiments.
Fig. 5. HGF increases GSH synthesis. (A) The ratio of reduced glutathione (GSH) to
oxidized glutathione (GSSG) determined by HPLC in serum-starved cells that were
treated with HGF (50 ng/ml) for 0–12 h. Each column represents the mean±SEM of
three independent experiments. ⁎pb0.05 against untreated cells. (B) Expression of γ-
glutamylcysteine synthetase (γ-GCS). Whole-cell lysates prepared from VL-17A cells
treated with HGF (50 ng/ml) at 0, 3, 6, and 12 h were immunoblotted with anti-γ-GCS.
A representative Western blot of three experiments is shown. (C) The ratio of GSH/
GSSG in hepatocytes treated or not with HGF (50 ng/ml) for 12 h, or ethanol (100 mM)
for 48 h, or the combination of both. Each column represents the mean±SEM of three
independent experiments. ⁎pb0.05 against untreated cells. &pb0.05 against EtOH-
treated cells.
Fig. 6. HGF enhances the main antioxidant enzymes. (A) Expression of catalase and
SOD1.Whole-cell lysates prepared fromVL-17A cells treated with HGF (50 ng/ml) for 0,
3, 6, and 12 h were immunoblotted with anti-catalase and anti-SOD1. A representative
Western blot of three experiments is shown. (B) VL-17A cells were pretreated with the
PI3K inhibitor wortmannin (W; 100 nM), Akt inhibitor II (AI; 10 μM), or NF-κB inhibitor
SN50 (SN; 30 μM) for 30 min and then treated with HGF (50 ng/ml) for 12 h.
Antioxidant enzymes were immunoblotted with anti-catalase and anti-SOD1. A
representative Western blot of three experiments is shown.
429A. Valdés-Arzate et al. / Free Radical Biology & Medicine 47 (2009) 424–430
expression of γ-GCS in bile duct epithelial cells [7] and an increased
GSH synthesis in rat hepatocytes and H4IIE cells [33,36]. It is clear that
GSH homeostasis is one of the main survival systems that are
modulated by HGF in response to oxidative stress.
In addition to GSH synthesis and γ-GCS expression promoted by
HGF, our data revealed that some antioxidant proteins are induced by
the action of this growth factor. HGF stimulated the expression of the
main antioxidant proteins such as SOD1 and catalase, but failed for
GSHPx. Recently it has been published that in bile duct epithelial cells,
HGF induced the expression of γ-GCS and GSH reductase, whereas no
effect was observed for SOD1, catalase, and GSHPx [7]. This differential
gene expression suggests that HGF activities are cell-type-dependent,
even in liver cell populations. Hepatocytes are the main cell type that
detoxifies EtOH, and it is in these cells that more antioxidant
protection is needed in addition to the GSH system.
In conclusion, this work sustains the predominant role of HGF in
the antioxidant protection against EtOH-induced oxidative stress, by a
mechanism dependent on the activation of the PI3K/Akt/NF-κB
signaling pathway.
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